Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risks

Obstetrics and Gynecology

Volumn 115, Issue 2 PART 1, 2010, Pages 243-248

  Castle, Philip E ^a   Fetterman, Barbara ^b   Poitras, Nancy ^b   Lorey, Thomas ^b   Shaber, Ruth ^b   Kinney, Walter ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CANCER SCREENING; CYTOLOGY; ENDOMETRIUM CANCER; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; WART VIRUS; ENDOMETRIUM; ENDOMETRIUM TUMOR; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PATHOLOGY; UTERINE CERVIX; UTERINE CERVIX TUMOR; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 76549106083     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181c799a3     Document Type: Article

References (17)

1. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
2. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 2007;11:201-22.
3. Westin MC, Derchain SF, Rabelo-Santos SH, Angelo-Andrade LA, Sarian LO, Oliveira E, et al. Atypical glandular cells and adenocarcinoma in situ according to the Bethesda 2001 classification: cytohistological correlation and clinical implications. Eur J Obstet Gynecol Reprod Biol 2008;139:79-85.
4. Diaz-Montes TP, Farinola MA, Zahurak ML, Bristow RE, Rosenthal DL. Clinical utility of atypical glandular cells (AGC) classification: cytohistologic comparison and relationship to HPV results. Gynecol Oncol 2007;104:366-71.
5. Kumar N, Bongiovanni M, Molliet MJ, Pelte MF, Egger JF, Pache JC. Reclassification and analysis of clinical significance of atypical glandular cells on ThinPrep using Bethesda 2001: Geneva experience. Swiss Med Wkly 2007;137:635-41.
6. Lai CR, Hsu CY, Tsay SH, Li AF. Clinical significance of atypical glandular cells by the 2001 Bethesda System in cytohistologic correlation. Acta Cytol 2008;52:563-7.
7. Irvin W, Evans SR, Andersen W, Jazaeri A, Taylor P, Stoler M, et al. The utility of HPV DNA triage in the management of cytological AGC. Am J Obstet Gynecol 2005;193:559-65.
8. Schnatz PF, Sharpless KE, O'Sullivan DM. Use of human papillomavirus testing in the management of atypical glandular cells. J Low Genit Tract Dis 2009;13:94-101.
9. Zhao C, Florea A, Onisko A, Austin RM. Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic women's hospital laboratory employing sensitive screening methods. Gynecol Oncol 2009;114:383-9.
10. Sharpless KE, O'Sullivan DM, Schnatz PF. The utility of human papillomavirus testing in the management of atypical glandular cells on cytology. J Low Genit Tract Dis 2009;13:72-8.
11. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007;370:890-907.
12. Cook LS, Weiss NS, Doherty JA, Chen C. Endometrial cancer. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. 3rd ed. New York (NY): Oxford; 2006. p. 1027-43.
13. Confortini M, Di Bonito L, Carozzi F, Ghiringhello B, Mon-tanari G, Parisio F, et al. Interlaboratory reproducibility of atypical glandular cells of undetermined significance: a national survey. Cytopathology 2006;17:353-60.
14. Long JS. Nominal outcomes: multinomial logit and related models. In: Regression models for categorical and limited dependent variables. Thousand Oaks (CA): Sage Publications; 1997. p. 148-86.
15. Wang SS, Sherman ME, Hildesheim A, Lacey JV Jr, Devesa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 2004;100: 1035-44.
16. Guido R, Schiffman M, Solomon D, Burke L, ASCUS LSIL Triage Study (ALTS) Group. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-posi-tive atypical squamous cells of undetermined significance: a two-year prospective study. Am J Obstet Gynecol 2003;188: 1401-5.
17. Gage JC, Hanson VW, Abbey K, Dippery S, Gardner S, Kubota J, et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 2006;108:264-72.